Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 1, 2006
A daily diary study of late-life depression
Lara G Chepenik, Thomas Ten Have, David Oslin, et al.
American Health & Drug Benefits
|
June 20, 2017
Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis
Tope Olufade, Amanda M Kong, Nicole Princic, et al.
American Health & Drug Benefits
|
September 9, 2016
Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain
Ancilla W Fernandes, David M Kern, Catherine Datto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 28, 2005
Probing for affective side effects of drugs used in geriatric practice: use of daily diaries to test for effects of metoclopramide and naproxen
Ira R Katz, Knashawn Morales, Catherine Datto, et al.
The International Journal of Neuropsychopharmacology
|
February 24, 2010
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
Nizar El-Khalili, Mark Joyce, Sarah Atkinson, et al.
Orphanet Journal of Rare Diseases
|
November 25, 2021
Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents
Calvin N Ho, Sean O'Quinn, Julie Bailey, et al.
Journal of Affective Disorders
|
August 10, 2010
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study
Brian Bortnick, Nizar El-Khalili, Michael Banov, et al.
International Clinical Psychopharmacology
|
October 10, 2015
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studies
Robert S Brody, Charles L Liss, Heather Wray, et al.
International Clinical Psychopharmacology
|
March 15, 2013
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy
Michael E Thase, Stuart Montgomery, George I Papakostas, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 1, 2006
A daily diary study of late-life depression
Lara G Chepenik, Thomas Ten Have, David Oslin, et al.
American Health & Drug Benefits
|
June 20, 2017
Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis
Tope Olufade, Amanda M Kong, Nicole Princic, et al.
American Health & Drug Benefits
|
September 9, 2016
Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain
Ancilla W Fernandes, David M Kern, Catherine Datto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 28, 2005
Probing for affective side effects of drugs used in geriatric practice: use of daily diaries to test for effects of metoclopramide and naproxen
Ira R Katz, Knashawn Morales, Catherine Datto, et al.
The International Journal of Neuropsychopharmacology
|
February 24, 2010
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study
Nizar El-Khalili, Mark Joyce, Sarah Atkinson, et al.
Orphanet Journal of Rare Diseases
|
November 25, 2021
Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents
Calvin N Ho, Sean O'Quinn, Julie Bailey, et al.
Journal of Affective Disorders
|
August 10, 2010
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study
Brian Bortnick, Nizar El-Khalili, Michael Banov, et al.
International Clinical Psychopharmacology
|
October 10, 2015
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studies
Robert S Brody, Charles L Liss, Heather Wray, et al.
International Clinical Psychopharmacology
|
March 15, 2013
Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy
Michael E Thase, Stuart Montgomery, George I Papakostas, et al.
Page
of 4